TLRY Tilray Inc

Price (delayed)

$19.70

Market cap

$2.51B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.56

Enterprise value

$2.83B

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Tilray is a Canadian pharmaceutical and cannabis company, incorporated in the United States with primary operations headquartered in Toronto, Ontario. Tilray also has operations in Australia, New Zealand, Germany, Portugal, ...

Highlights

TLRY's revenue is up by 48% year-on-year
Tilray's quick ratio has increased by 35% from the previous quarter and by 9% YoY
TLRY's equity has dropped by 55% year-on-year but it is up by 42% since the previous quarter
Tilray's gross margin has plunged by 188% YoY and by 34% from the previous quarter
Tilray's gross profit has decreased by 34% from the previous quarter

Key stats

What are the main financial stats of TLRY
Market
Shares outstanding
127.18M
Market cap
$2.51B
Enterprise value
$2.83B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
13.42
Price to sales (P/S)
12.66
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
14.11
Earnings
Revenue
$200.86M
EBIT
-$457.82M
EBITDA
-$438.18M
Free cash flow
-$249.03M
Per share
EPS
-$4.56
Free cash flow per share
-$1.93
Book value per share
$1.47
Revenue per share
$1.56
TBVPS
$4.24
Balance sheet
Total assets
$887.36M
Total liabilities
$700.64M
Debt
$484.1M
Equity
$186.72M
Working capital
$171.35M
Liquidity
Debt to equity
2.59
Current ratio
2.28
Quick ratio
1.35
Net debt/EBITDA
-0.75
Margins
EBITDA margin
-218.2%
Gross margin
-23.8%
Net margin
-243.1%
Operating margin
-195.7%
Efficiency
Return on assets
-54.9%
Return on equity
-246%
Return on invested capital
-63.3%
Return on capital employed
-60.7%
Return on sales
-227.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

TLRY stock price

How has the Tilray stock price performed over time
Intraday
6.14%
1 week
74.18%
1 month
150.32%
1 year
-7.77%
YTD
138.5%
QTD
138.5%

Financial performance

How have Tilray's revenue and profit performed over time
Revenue
$200.86M
Gross profit
-$47.82M
Operating income
-$393.15M
Net income
-$488.26M
Gross margin
-23.8%
Net margin
-243.1%
Tilray's gross margin has plunged by 188% YoY and by 34% from the previous quarter
The operating margin has plunged by 149% YoY and by 2.3% from the previous quarter
The net margin has plunged by 148% YoY but it has grown by 7% from the previous quarter
TLRY's revenue is up by 48% year-on-year

Growth

What is Tilray's growth rate over time

Valuation

What is Tilray stock price valuation
P/E
N/A
P/B
13.42
P/S
12.66
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
14.11
The EPS is up by 7% since the previous quarter
The price to book (P/B) is 168% higher than the last 4 quarters average of 5.0
TLRY's equity has dropped by 55% year-on-year but it is up by 42% since the previous quarter
TLRY's price to sales (P/S) is 134% more than its last 4 quarters average of 5.4
TLRY's revenue is up by 48% year-on-year

Efficiency

How efficient is Tilray business performance
The ROS has dropped by 188% year-on-year but it is up by 7% since the previous quarter
The company's return on equity fell by 20% QoQ
The ROIC has grown by 6% from the previous quarter
The company's return on assets rose by 2.5% QoQ

Dividends

What is TLRY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TLRY.

Financial health

How did Tilray financials performed over time
Tilray's total assets is 27% higher than its total liabilities
Tilray's quick ratio has increased by 35% from the previous quarter and by 9% YoY
Tilray's current ratio has increased by 29% QoQ but it has decreased by 10% YoY
The debt is 159% more than the equity
Tilray's debt to equity has surged by 147% YoY but it has decreased by 29% QoQ
TLRY's equity has dropped by 55% year-on-year but it is up by 42% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.